JCAM
RVNC

Jericho Capital Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Jericho Capital Asset Management’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,438,669
Closed -$46.3M – 33
2023
Q1 		$46.3M Buy
1,438,669
+503,000
+54% +$16.2M 1.92% 20
2022
Q4 		$17.3M Buy
935,669
+221,669
+31% +$4.09M 1.28% 20
2022
Q3 		$19.3M Buy
+714,000
New +$19.3M 1.22% 19